Zelboraf tablets (Vemurafenib)
What is Zelboraf tablets (Vemurafenib)
Zelboraf tablets is an oral, small molecule, kinase inhibitor for the treatment of Metastatic Melanoma.
Its use and Indications
Zelboraf tablets (Vemurafenib) is indicated for the treatment of unresectable or Metastatic Melanoma with detection of a BRAF mutation.
For treatment related information, please consult your treating Physician.
Zelboraf (Vemurafenib) is available in 240 mg tablets, and is presented in a box of 56 Tablets.
Storage and handling
Store at 20°- 25° C, excursions permitted to 15° to 30° C.
How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
Ms Roche, Basel, Switzerland
Mob No: +91 7738100125, +91 7738151650
E Mail: email@example.com